Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Lightchain

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 11
Average round size
info
The average size of a deal this fund participated in
$61M
Portfolio companies 8
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.27
Exits 1
Key employees Soon

Areas of investment

  • Biotechnology
  • Health Diagnostics
  • Software
  • Health Care
  • Therapeutics

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Altpoint Capital Partners New York, New York, United States
Blue Rock Capital Delaware, United States, Wilmington
Cartesian Capital Group New York, New York, United States
Creative Wings -
GDI Capital -
Great Road Holdings Harrison, New York, United States
Juesheng Investment China, Hangzhou, Zhejiang
Kepha Partners Massachusetts, United States, Waltham
Lamp Post Group Chattanooga, Tennessee, United States
Mondelez International Deerfield, Illinois, United States
Otter Media California, Santa Monica, United States
Qixing Control Equipment China, Shaanxi, Xian Shi
SATUS Starter Kraków, Malopolskie, Poland
SMC Space Ventures -
Tekton Ventures California, San Francisco, United States
Tesla California, Palo Alto, United States
Third Derivative -
Whiteboard Capital India, Maharashtra, Mumbai
Zanichelli Venture Bologna, Emilia-Romagna, Italy

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Geneoscopy

Biotechnology
Genetics
Health Care
Health Diagnostics
$105M16 Nov 2021 City of Saint Louis, Missouri, United States

Wugen

Biotechnology
Therapeutics
$172M15 Jul 2021 St Louis, Missouri, United States

Arch Oncology

Biotechnology
$105M27 Apr 2021 California, United States

Mana Therapeutics

Biotechnology
$35M08 Jan 2021 Arlington, Virginia, United States

Geneoscopy

Biotechnology
Genetics
Health Care
Health Diagnostics
$6M02 Oct 2019 City of Saint Louis, Missouri, United States

Arch Oncology

Biotechnology
$50M25 Mar 2019 California, United States
News
Arch Oncology Secures $105M Series C

– Arch Oncology, a clinical-stage immuno-oncology company, has closed a $105m Series C financing co-led by Eventide Asset Management, Cowen Healthcare Investments and current investor 3×5 Partners.
– New investors in the round included Adage Capital Management, Point72 Asset Management, Avego Healthcare Capital, FMB Research and Broadfin Holdings.
– The company’s existing investors, including Roche Venture Fund, RiverVest Venture Partners, and Lightchain also participated in the round.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Lightchain?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 11
Average round size 61M
Peak activity year 2019
Lead investments 0
Follow on index 0.27
Exits 1
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Geneoscopy

Biotechnology
Genetics
Health Care
Health Diagnostics
$105M16 Nov 2021 City of Saint Louis, Missouri, United States

Wugen

Biotechnology
Therapeutics
$172M15 Jul 2021 St Louis, Missouri, United States

Arch Oncology

Biotechnology
$105M27 Apr 2021 California, United States

Mana Therapeutics

Biotechnology
$35M08 Jan 2021 Arlington, Virginia, United States

Geneoscopy

Biotechnology
Genetics
Health Care
Health Diagnostics
$6M02 Oct 2019 City of Saint Louis, Missouri, United States

Arch Oncology

Biotechnology
$50M25 Mar 2019 California, United States
Crunchbase icon

Content report

The following text will be sent to our editors: